Track topics on Twitter Track topics that are important to you
MEDx (Suzhou) Translational Medicine has collaborated with genomic medicine company Lucence for the development of cancer-care tests. As part of the strategic partnership, the companies will co-develo...
Lucence, a genomic medicine company developing blood-based tests for cancer screening and treatment selection, announced this week the close of a $20 million Series A funding round led by IHH Healthca...
MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - today announced an agreement to pursue a strategic partnership in China to co-develop cancer-c...
Lucence Diagnostics has entered an agreement with China's MEDx Translational Medicine to develop companion diagnostic cancer -More-
Lucence, a genomic medicine company that invents blood-based tests for cancer screening and treatment selection, announced today the close of USD $20 million in Series A funding. The round was led by...
Lucence is a genomic medicine company founded on a vision of a world without avoidable cancer deaths. The company develops non-invasive blood tests that improve cancer detection and treatment selecti...
We have published hundreds of Lucence news stories on BioPortfolio along with dozens of Lucence Clinical Trials and PubMed Articles about Lucence for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lucence Companies in our database. You can also find out about relevant Lucence Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...